Dale Curtis Hogue
Equibles does not estimate personal net worth.
About Dale Curtis Hogue
Earlier roles on record: Board Member at Alaunos Therapeutics, Inc. (TCRT) until July 17, 2025 and CEO and Board Member at Alaunos Therapeutics, Inc. (TCRT) until July 1, 2025. Alaunos Therapeutics, Inc. reported in an 8-K filed July 17, 2025 that Dale Curtis Hogue resigned as director. The proxy statement of Alaunos Therapeutics, Inc. reports total compensation of $308,344 for Dale Curtis Hogue in fiscal 2024, including a base salary of $233,974. Disclosed compensation is on record for 2 fiscal years.
“Mr. Jerman fills the vacancy created by Mr. Dale Curtis Hogue's resignation.”
Affiliation history
-
Start not stated–2025-07-01
-
Start not stated–2025-07-01
-
Start not stated–2025-07-17
Company network
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | Alaunos Therapeutics, Inc. (TCRT) | Interim Chief Executive Officer | $233,974 | $308,344 |
| 2023 | Alaunos Therapeutics, Inc. (TCRT) | Interim Chief Executive Officer | — | $48,153 |